Treatment Registry
TR-0464 ActiveRecorded September 2026

Compounded semaglutide

Sold by Meto · Injection, vial · every compounded semaglutide record

Recorded initial charges

First month

$228

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · GLP-1 family protocol · recorded initial monthly payment$199
Required membership · Monthly membership$29

Added from the figures recorded below.

Price

TermPer monthCharged today
GLP-1 family protocol

“GLP-1 family Compounded semaglutide and tirzepatide for appetite regulation and metabolic reset. Same active ingredients as Ozempic, Wegovy, Mounjaro and Zepbound — priced without the commercial-pharma markup. $199/mo”

Per month$199Charged today$199
Price sources
Visit Meto

We earn nothing from this link. It opens Meto's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PrescriberAsynchronous review
CancellationCan I cancel anytime? Yes — membership is month-to-month, and you can pause or cancel from your dashboard. No phone calls, no retention scripts.
MembershipRequired. $29 per month. Membership $29/month, billed at $320 annually. "Your membership unlocks clinician access and platform tools; peptide protocols are billed monthly based on the medication you're on", and the plan states "Cost of medication not included." ⛔ $29 × 12 is $348, so the annual price is a discount on the monthly rate rather than a restatement of it.

Not yet checked: pharmacy, states and consult fee.

Recorded from meto.co. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — Meto is a labs-first peptide platform; its 'GLP-1 family' protocol ($199/mo) is a single SKU covering EITHER compounded semaglutide (2.5 mg/mL) or tirzepatide (10 mg/mL) at the same price point, chosen by the clinician based on labs — not two separately priced products. On top of the $199/mo protocol price, every member also pays a separate $29/month membership fee that explicitly excludes medication cost, plus a one-time $149 lab panel required before matching to a protocol (not a recurring price, so not recorded as an entry).

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0464
Medication category
compounded semaglutide
Readings
1

Related records

Compounded semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 372 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Meto — compounded semaglutide (TR-0464). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0464

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.